Why the study?
Does point-of-care testing of H-FABP improve the early diagnosis of acute myocardial infarction compared to conventional cardiac markers?
Population
83 patients, including those with confirmed acute myocardial infarction, non-AMI cardiac diseases, and…
Comparison
Point-of-care-testing of heart-type fatty… vs Conventional cardiac biochemical markers.
Design
Cross-sectional
Authors
Loading...
H-FABP may aid superacute AMI detection but risks false positives; cross-sectional data leave POC utility versus troponin open.
Does point-of-care testing of H-FABP improve the early diagnosis of acute myocardial infarction compared to conventional cardiac markers?
Point-of-care testing for H-FABP provides high sensitivity but lower specificity compared to troponin T for detecting acute myocardial infarction within 3 hours of onset.
Tanaka et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: